Ignite Creation Date:
2025-12-25 @ 1:28 AM
Ignite Modification Date:
2026-01-22 @ 7:34 AM
Study NCT ID:
NCT00454194
Status:
COMPLETED
Last Update Posted:
2017-03-21
First Post:
2007-03-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Sponsor:
Alliance for Clinical Trials in Oncology
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Lung Cancer | View |